InvestorsHub Logo
icon url

McMagyar

02/26/17 11:54 AM

#93322 RE: XenaLives #93317

Not all.. did you notice last addition to board was from Non Pharma focus?
My mind can't find the word but ..
Osteopathic. Anavex gets where A2-73 may go above and beyond the Prescription Market..
https://en.m.wikipedia.org/wiki/Osteopathic_medicine_in_the_United_States
icon url

bocce

02/26/17 12:47 PM

#93329 RE: XenaLives #93317

If the compound is properly considered a "supplement", then the FDA is not authorized to review the product for safety and effectiveness before the product is marketed. The manufacturer and distributor of the product are responsible for making sure the product is safe before the product goes to market.



https://www.fda.gov/Food/DietarySupplements/